The Impact of the COVID-19 Pandemic on the Transplant Pharmacist Workforce.
J Pharm Pract
; : 8971900221131906, 2022 Oct 07.
Article
en En
| MEDLINE
| ID: mdl-36206374
ABSTRACT
Background:
The COVID-19 pandemic has placed an unprecedented strain on the US healthcare system, greatly impacting transplant centers.Objective:
The purpose of this survey was to evaluate the impact of the COVID-19 pandemic on the transplant pharmacist workforce.Methods:
A survey was disseminated electronically to assess the impact of the COVID-19 pandemic on the transplant pharmacist workforce. Respondents were asked to give background regarding transplant center, patient, population, and departmental staffing.Results:
There were 67 total respondents from 56 transplant centers. In response to the COVID-19 pandemic, 55% of centers reported stopping non-life saving transplants, and a majority (89%) stopped living donor transplants altogether. The banning of caregivers on-site during education, reduction of bedside education teaching, and cancelling of group teaching classes occurred at 46%, 40%, and 22% of centers, respectively. Consequently, 42% of pharmacists surveyed felt that their confidence in patient and caregiver's understanding of medications had decreased since these changes have been implemented.Conclusions:
Pharmacist perception of patient and caregiver understanding of transplant medications has decreased since before the COVID-19 pandemic. As health systems strategize resource allocation throughout the pandemic, the importance of patient education must be prioritized to sustain and improve transplant outcomes.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Idioma:
En
Revista:
J Pharm Pract
Asunto de la revista:
FARMACIA
Año:
2022
Tipo del documento:
Article
País de afiliación:
Estados Unidos